Verve Therapeutics
VERV
#7075
Rank
C$0.54 B
Marketcap
$6.42
Share price
1.10%
Change (1 day)
-62.14%
Change (1 year)

Verve Therapeutics (VERV) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : C$0.21 Billion

According to Verve Therapeutics's latest financial reports the company's total liabilities are C$0.21 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Verve Therapeutics - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$0.20 B16.71%
2022-12-31C$0.17 B410.22%
2021-12-31C$34.11 M-81.2%
2020-12-31C$0.18 B237.25%
2019-12-31C$53.8 M